恒瑞医药(01276.HK)收到国家药监局核准签发关于HRS-6093片的《药物临床试验批准通知书》

Group 1 - The company, Heng Rui Medicine (01276.HK), has received approval from the National Medical Products Administration (NMPA) for the clinical trial of HRS-6093 tablets [1] - The clinical trials for HRS-6093 will commence shortly following the approval [1]